TY - JOUR T1 - Sarilumab for Previously-Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal JO - Pharmacoeconomics UR - https://eprints.whiterose.ac.uk/id/eprint/131862 PY - 2018/06/08 AU - Bermejo I AU - Ren S AU - Simpson E AU - Clowes M AU - Scott DL AU - Young A AU - Stevenson M ED - DO - DOI: 10.1007/s40273-018-0677-7 PB - Springer Nature VL - 36 IS - 12 SP - 1427 EP - 1437 Y2 - 2025/05/25 ER -